Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization

The incidence of antiplatelet factor-4/heparin antibody formation in patients who receive contemporary doses of unfractionated heparin in the setting of percutaneous coronary revascularization is unknown. Also unknown is the ability of these antibodies to activate platelets or adversely affect clini...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2005-03, Vol.95 (6), p.744-747
Hauptverfasser:	Gluckman, Tyler J., Segal, Jodi B., Fredde, Natalie L., Saland, Kenneth E., Jani, Jayesh T., Walenga, Jeanine M., Prechel, M. Margaret, Citro, Kathleen M., Zidar, David A., Fox, Emily, Schulman, Steven P., Kickler, Thomas S., Rade, Jeffrey J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angina Pectoris - immunology Angina Pectoris - mortality Angina Pectoris - therapy Angioplasty, Balloon, Coronary Antibody Formation - drug effects Antibody Formation - immunology Biological and medical sciences Cardiology Cardiology. Vascular system Clinical outcomes Coronary Disease - immunology Coronary Disease - mortality Coronary Disease - therapy Drug therapy Female Follow-Up Studies Heparin - administration & dosage Heparin - adverse effects Heparin - immunology Humans Immune Complex Diseases - chemically induced Immune Complex Diseases - immunology Immune Complex Diseases - mortality Immunoglobulins Male Medical sciences Middle Aged Myocardial Infarction - immunology Myocardial Infarction - mortality Myocardial Infarction - therapy Platelet Activation - drug effects Platelet Activation - immunology Platelet Factor 4 - immunology Purpura, Thrombocytopenic, Idiopathic - chemically induced Purpura, Thrombocytopenic, Idiopathic - diagnosis Purpura, Thrombocytopenic, Idiopathic - immunology Purpura, Thrombocytopenic, Idiopathic - mortality Recurrence Risk Factors Serotonin - blood Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!